News Feed
Viewing items with Category: All Categories, Year: All Years
![USF alumna Stefania Alastre](/images/news/2021/coph-and-moffitt-cancer-center-take-steps-to-diversify-the-field-of-genetic-counseling/coph-genetics-490-327.jpg)
COPH and Moffitt Cancer Center take steps to diversify the field of genetic counseling
The USF College of Public Health made headlines in 2016 as the first university in Florida to offer a MSPH degree in genetic counseling. Now it’s getting noticed again with its newest graduate Stefania Alastre becoming the first Spanish-speaking genetic counselor for Moffitt Cancer Center.
May 17, 2021USF Health, University News
![A graphic illustration showing a brain with electrical signals around it](/images/news/2021/usf-team-uses-new-neuroimaging-technique-to-study-physiological-effects-of-brain-stimulation-to-treat-depression/brain-stimulation-490-327.jpg)
USF team uses new neuroimaging technique to study physiological effects of brain stimulation to treat depression
Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. A small coil positioned near the scalp generates repetitive, pulsed magnetic waves that pass through the skull and stimulate brain cells to relieve symptoms of depression. The procedure has few side effects and is typically prescribed as an alternative or supplemental therapy when multiple antidepressant medications and/or psychotherapy do not work.
May 4, 2021Research and Innovation, USF Health
![A vial of the Pfizer/BioNTech COVID-19 vaccine](/images/news/2021/nih-study-of-allergic-reactions-to-moderna-pfizer-biontech-covid-19-vaccines-begins-at-usf-health/vaccine-490-327.jpg)
NIH study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines begins at USF Health
USF Health is participating in a National Institutes of Health clinical trial to determine whether highly allergic people or those with mast cell disorders are at greater risk for severe, immediate allergic reactions to the Moderna or Pfizer-BioNTech COVID vaccines. A mast cell disorder is caused by a type of white blood cell that is abnormal, overly active or both, predisposing a person to life-threatening reactions that resemble allergic reactions.
April 14, 2021COVID-19, Research and Innovation, USF Health
![Pain Fellows get hands on experience during cadaver course](/images/news/2021/usf-college-of-nursing-works-to-battle-opioid-crisis/painfellowshipmain490x328.jpg)
USF College of Nursing works to battle opioid crisis
The University of South Florida College of Nursing is combatting the opioid crisis in rural America by equipping advanced pain specialists with integrative pain management techniques.
April 12, 2021USF Health
![Mosquitoes used by Dr. Adams and his team to study malaria parasites are kept in secure containers in an insectary at US](/images/news/2021/usf-health-global-team-search-vaccine-malaria/malaria-mosquito-container-490-327.jpg)
USF Health-led global team searches for vaccine to prevent P. vivax malaria
With the support of a five-year, $4.86-million National Institutes of Health grant, Distinguished University/USF Health Professor John Adams, PhD, leads a team of international researchers focused on accelerating the discovery of a vaccine against Plasmodium vivax malaria, a major global health problem.
April 12, 2021USF Health
![A portrait of USF researcher Jerri Edwards](/images/news/2021/usf-awarded--44-million-nih-grant-to-test-whether-computerized-brain-training-can-reduce-dementia-risk-in-older-adults/edwards-490-327.jpg)
USF awarded five-year, $44.4 million NIH grant to test whether computerized brain training reduces dementia risk in older adults
The National Institutes of Health has awarded the University of South Florida total expected funds of $44.4 million over the next five years to study whether computerized brain training exercises can reduce the risk of mild cognitive impairment, and dementias like Alzheimer’s disease, in older adults.
April 6, 2021Research and Innovation, USF Health
![A graphic depiction of COVID-19 virus](/images/news/2021/coph-research-team-finds-chlorine-dioxide-gas-99-91-effective-against-covid-19-virus/coph-490-327.jpg)
Public Health research team finds chlorine dioxide gas 99.91% effective against COVID-19 virus
COVID-19 has taught us a lot of things. And one of the more important lessons has been the need for thorough, fast and effective disinfecting measures. A team of researchers from the USF College of Public Health’s Center for Environmental/Occupational Risk Analysis and Management set out to determine how effective commercially available chlorine dioxide gas products were in reducing COVID-19 viral loads on face masks and surfaces.
March 22, 2021Research and Innovation, USF Health
![A Morsani College of Medicine student receiving their Match Day residency information](/images/news/2021/usf-health-senior-medical-students-match-to-residencies/match-day-490-327.jpg)
USF Health senior medical students match to residencies
About 170 senior medical students from the USF Health Morsani College of Medicine were successfully matched and learned where they will spend their residency training after graduation from medical school in May.
March 22, 2021USF Health, University News
![A graphic showing COVID-19 research with the text,](/images/news/2021/usf-community-demonstrates-critical-leadership-in-year-long-response-to-covid19/covid-490-327.jpg)
USF community demonstrates critical leadership in year-long response to COVID-19
The leadership demonstrated throughout the COVID-19 pandemic by the University of South Florida has become a true testament to the spirit of faculty, staff and students – a spirit of perseverance, collaboration and community partnership, despite the emotional and often taxing circumstances that have become part of many daily lives.
March 12, 2021COVID-19, USF Health, University News
![Jose D. Herazo-Maya, associate chief of pulmonary, critical care and sleep medicine](/images/news/2021/1-million-gift-to-usf-will-advance-lung-research/1-million-gift-to-usf-will-advance-lung-research-listing.jpg)
$1 million gift to USF will advance lung research
The University of South Florida has received a $1 million gift to fund research to detect and prevent severe lung scarring. Philanthropist Timothy Ubben made the gift to support research led by his doctor, Jose D. Herazo-Maya, USF Health’s newly appointed associate chief of pulmonary, critical care and sleep medicine.
February 17, 2021Research and Innovation, USF Health, University News
![A stock image of a heart rate monitor](/images/news/2020/research-team-uncovers-significant-reason-older-adults-are-at-increased-risk-of-suffering-heart-attack/heart-rate-490-327.jpg)
USF research team uncovers significant reason older adults are at increased risk of suffering a heart attack
A team of researchers in the USF Department of Surgery has made a key discovery as to why we become more susceptible to heart disease as we age. The human body, especially the heart, is dependent on the mitochondria, the part of the cell responsible for producing energy to maintain organ function. The protein, Sesn2, is located inside the mitochondria and plays a pivotal role in protecting the heart from stress.
December 3, 2020Research and Innovation, USF Health
![Tampa General Hospital](/images/news/2020/usf-health-and-tampa-general-hospital-selected-to-participate-in-the-novavax-covid-19-caccine-phase-3-clinical-trial/usf-health-and-tampa-general-hospital-selected-to-listing-image.jpg)
USF Health and Tampa General Hospital selected to participate in the Novavax COVID-19 vaccine Phase 3 clinical trial
USF Health and Tampa General Hospital have been selected as a site for a clinical trial testing the Novavax NVX-CoV2373 vaccine for COVID-19. They join over 100 research sites expecting to enroll more than 30,000 adult participants as part of the global search for a safe and effective vaccine to prevent COVID-19.
December 3, 2020COVID-19, USF Health